Sign In
Buy MCK
$745.12
-5.51 (-0.734%)
At Close: Jun 22, 2026
McKesson (MCK) Stock Sinks As Market Gains: Here's Why
06:51pm, Thursday, 18'th Jun 2026
McKesson (MCK) closed the most recent trading day at $750.63, moving 3.74% from the previous trading session.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
10:01am, Wednesday, 10'th Jun 2026
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Here's Why McKesson (MCK) is a Strong Value Stock
10:41am, Tuesday, 09'th Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
10:51am, Monday, 08'th Jun 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
McKesson Closes Strategic Investment with Apollo Funds for Minority Interest in Medical-Surgical Solutions
08:00am, Tuesday, 02'nd Jun 2026
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today the successful completion of the previously announced minority ownership interest investment from funds managed by affi
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Wednesday, 27'th May 2026
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now
01:21pm, Friday, 22'nd May 2026
McKesson's oncology growth, GLP-1 momentum and RxTS expansion support earnings strength, but pricing reform and margin pressures pose risks.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
10:01am, Thursday, 14'th May 2026
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
McKesson Corporation (MCK) Presents at Bank of America Global Healthcare Conference 2026 Transcript
03:10pm, Tuesday, 12'th May 2026
McKesson Corporation (MCK) Presents at Bank of America Global Healthcare Conference 2026 Transcript
McKesson Q4 Earnings Call Highlights
03:09pm, Monday, 11'th May 2026
McKesson NYSE: MCK reported a stronger fiscal fourth quarter and full fiscal 2026 performance, with executives pointing to growth across its oncology, multispecialty, pharmaceutical distribution and p
MCK Stock Falls Despite Q4 Earnings Beat, Sales Miss, Margins Up
11:51am, Friday, 08'th May 2026
McKesson beats Q4 EPS estimates as oncology and specialty distribution growth offset revenue miss and lift segment margins.
McKesson Corporation (MCK) Q4 2026 Earnings Call Transcript
09:01pm, Thursday, 07'th May 2026
McKesson Corporation (MCK) Q4 2026 Earnings Call Transcript
Compared to Estimates, McKesson (MCK) Q4 Earnings: A Look at Key Metrics
07:01pm, Thursday, 07'th May 2026
Although the revenue and EPS for McKesson (MCK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street
McKesson (MCK) Surpasses Q4 Earnings Estimates
06:55pm, Thursday, 07'th May 2026
McKesson (MCK) came out with quarterly earnings of $11.69 per share, beating the Zacks Consensus Estimate of $11.56 per share. This compares to earnings of $10.12 per share a year ago.
McKesson expects 2027 profit slightly above estimates on drug distribution strength
05:50pm, Thursday, 07'th May 2026
McKesson forecast 2027 profit slightly above Wall Street expectations after beating first-quarter profit estimates on Thursday, as the U.S. drug distributor banks on strength in its oncology and
